A Phase 2 Study of GS-5423 and GS-2872 in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults (NCT05729568)
GS-US-536-5939
This trial is No longer recruiting
Registration number NCT05729568
Program & service
This trial is being run with the Infectious Diseases service, and as part of the Infectious Diseases program.
Trial phase
Phase 2
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor James McMahon
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR